Reply to Y. Inagaki et al

J Clin Oncol. 2020 May 20;38(15):1749-1750. doi: 10.1200/JCO.20.00295. Epub 2020 Apr 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors*
  • Inflammatory Bowel Diseases*
  • Radioimmunotherapy

Substances

  • Immune Checkpoint Inhibitors